去纤维钠多少钱一盒？

Also called defibrinoside, the English name is defiteli. It was first developed by Gentium Pharmaceuticals in Italy and was launched in the EU in 2013. Defibrotide sodium is a good medicine for the treatment of hepatic veno-occlusive disease (HVOD), also known as sinusoidal obstruction syndrome (SOS). It can be used not only to treat adults, but children can also benefit from it.

Defibrotide sodium (defiteli) is an injectable dosage form based on the patient's weight. The recommended dose for adult and pediatric patients is 6.25 mg/kg given every 6 hours as a 2-hour intravenous infusion. The minimum administration time is 21 days. If signs and symptoms of hepatic veno-occlusive disease have not resolved after 21 days, continue defibrotide until resolution of hepatic veno-occlusive disease or for a maximum of 60 days.

In clinical trials, defibrotide sodium (defiteli) can very well prevent the occurrence of HVOD, and when combined with heparin, the incidence of side effects is very low and the safety is relatively high. In 2016, defibrinated sodium was approved by the US FDA for marketing. Defibrotide sodium has also been granted "orphan drug" designation.

How much does a box of fiber-free sodium cost?

Defibrotide sodium (defiteli) is not officially launched in my country, but may be available in some hospitals in Hong Kong. The current international price of defibrinated sodium is around $22,000. If the patient is inconvenient to purchase it by himself, he or she can consult the medical companion’s travel service for specific purchase information.

Caution should be taken when using (defiteli) not to be co-administered with other intravenous drugs at the same time and in the same intravenous line. If concurrent use with a systemic anticoagulant or fibrinolytic therapy (excluding use for routine maintenance or reopening of central venous lines) may increase the risk of bleeding, use is contraindicated in patients with defibrinated sodium or known hypersensitivity to any excipient.